Skip to main content
Download PDF

Predictive value of nutritional indices for left atrial thrombus in patients with valvular atrial fibrillation

BMC Cardiovascular Disorders volume 23, Article number: 526 (2023) Cite this article

Abstract

Background

The prognostic nutritional index (PNI) and geriatric nutritional risk index (GNRI) are well known indicators for adverse outcomes in various diseases, but there is no evidence on their association with the risk of left atrial thrombus (LAT) in patients with valvular atrial fibrillation (VAF).

Methods

A comparative cross-sectional analytical study was conducted on 433 VAF patients. Demographics, clinical characteristics and echocardiographic data were collected and analyzed. Patients were grouped by the presence of LAT detected by transesophageal echocardiography.

Results

LAT were identified in 142 patients (32.79%). The restricted cubic splines showed an L-shaped relationship between PNI and LAT. The dose-response curve flattened out near the horizontal line with OR = 1 at the level of 49.63, indicating the risk of LAT did not decrease if PNI was greater than 49.63. GNRI was negative with the risk of LAT and tended to be protective when greater than 106.78. The best cut-off values of PNI and GNRI calculated by receiver operating characteristics curve to predict LAT were 46.4 (area under these curve [AUC]: 0.600, 95% confidence interval [CI]:0.541–0.658, P = 0.001) and 105.7 (AUC: 0.629, 95% CI:0.574–0.684, P<0.001), respectively. Multivariable logistic regression analysis showed that PNI ≤ 46.4 (odds ratio: 2.457, 95% CI:1.333–4.526, P = 0.004) and GNRI ≤ 105.7 (odds ratio: 2.113, 95% CI:1.076–4.149, P = 0.030) were independent predictors of LAT, respectively.

Conclusions

Lower nutritional indices (GNRI and PNI) were associated with increased risk for LAT in patients with VAF.

Peer Review reports

Introduction

Atrial fibrillation (AF) is the most common cardiac arrhythmia with increasing health-related burden. The current prevalence of AF is between 2% and 4%, which is expected to continue rising owing to extended longevity [1]. AF is associated with an increased risk of stroke and thromboembolism, resulting to substantial morbidity and mortality. Among different underlying diseases, AF patients with valvular heart disease are at the highest risk of ischemic stroke [2, 3]. Valvular atrial fibrillation (VAF) predominantly affects large populations in many low- and middle- income countries. In a global registry study, VAF accounted for 8.8% of AF patients in Western Europe, but 32.6% in Africa and 46.7% in India [4]. To make matters worse, stroke related to VAF occurs in a much younger population, leading to consequent loss of manpower and resultant heavy economic burdens. Disorganized electrical activity in the atrium is the main characteristic of AF, which prompts ineffective contraction and stasis of blood. Blood stasis gives rise to thrombogenic tendency in the left atrium. It has been well recognized that the left atrial thrombus (LAT) formation is the primary cause of stroke in patients with AF [5]. Therefore, it is essential to identify VAF patients at high risk of LAT and provide appropriate treatment to protect them from stroke.

Malnutrition is a common status in patients with chronic diseases, especially in low- and middle- income countries. More than a third of AF patients have a moderate to high risk of malnutrition [6]. Nutritional deficiencies may also be a driver of disease progression as part of a vicious cycle associated with chronic systematic inflammation, neurohumoral activation and cachexia [7]. Various systems and scores have been proposed for evaluation of malnutrition. Among theses assessment tools, the prognostic nutritional index (PNI) and geriatric nutritional risk index (GNRI) have been widely used for screening malnutrition in clinical practice. Malnutrition determined by these scoring methods is an independent predictor of increased mortality in AF patients [6, 8]. However, the predictive value of PNI and GNRI for LAT in patients with VAF remains unknown.

Accordingly, we conducted this study to investigate the association between nutritional indices and LAT in patients with VAF undergoing transesophageal echocardiography (TEE).

Methods

Study population

Consecutive hospitalized patients with VAF who undertook TEE to determine LAT in Henan Provincial People’s Hospital between January 2015 and September 2022 were enrolled in our study. VAF is defined according to guideline as AF patients with moderate or severe mitral stenosis and those with mechanical prosthetic heart valve(s) [1]. First-diagnosed AF was defined as AF not diagnosed previously, irrespective of its duration or the presence/severity of AF-related symptoms [1]. Patients with missing blood test, acute and/or chronic infection and hematologic malignancies were excluded. The flowchart of patient inclusion was shown in Fig. 1. The study protocol was approved by the Ethics Committee of the Henan Provincial People’s Hospital. The need for informed consent was waived by the Ethics Committee of the Henan Provincial People’s Hospital, because of the retrospective nature of the study.

Fig. 1
figure 1

Flow diagram showing screening and recruitment of the study population. VAF, valvular atrial fibrillation; LAT, left atrial thrombus

Full size image

Data collection

Patients’ clinical data prior to TEE were retrieved from medical records, including age, gender, type of atrial fibrillation, comorbidities (coronary heart disease, heart failure, hypertension, diabetes, history of stroke), oral anticoagulant therapy, laboratory variables and echocardiographic parameters. Body mass index (BMI) was calculated as weight divided by height squared (kg/m2). Venous blood samples after 12 h fasting were collected from each patient after admission and before TEE examination. All biochemical tests were measured in the laboratory of the testing center for examination by standard techniques. Estimate glomerular filtration rate was calculated using the Cockcroft-Gault equation.

Nutritional indices equations

Nutritional indices were calculated using these equations:

PNI = 10 × serum albumin (g/dl) + 0.005 × total lymphocyte count (mm3) [9].

GNRI = 14.89 × serum albumin (g/dl) +41.7 × (body weight/ideal body weight) [10].

Echocardiographic parameters

After admission, transthoracic echocardiography and TEE were performed according to international guidelines. LAT referred to a highly reflective and well-circumscribed mass with uniform consistency and different texture from the atrial wall in TEE [11]. The peak and mean gradients, which were measured by the mitral inflow velocities with continuous wave Doppler ultrasound scanning from the apical view, were used to evaluate the severity of mitral stenosis. The area of mitral valve was calculated in the short-axis view by pressure half-time method and planimetry of the mitral valve orifice in early diastole phase. Moderate or severe mitral stenosis referred to patients with a valve area of < 1.5 cm2 or a mean gradient of > 5 mmHg. Left atrial diameter (LAD) and left ventricular ejection fraction were measured from M-mode or 2D view in the parasternal long-axis projection.

Statistical analysis

Normally distributed continuous variables were presented as mean (± standard deviation) and compared by Student’s t tests. Continuous variables with non-normally distribution were represented as median (inter-quartile range), and compared by the Mann-Whitney U test. Categorical variables in each group were presented as numbers and percentages, and compared by the Chi-square test. Spearman test was utilized for describing the correlation between nutritional indices and clinical variables. Restricted cubic splines were plotted to illustrate the dose-response association between nutritional indices and the risk of LAT. Four knots were placed at the 5th, 35th, 65th, and 95th percentiles of nutritional indices. Receiver operating characteristic (ROC) curves were established to evaluate predictive ability of nutritional indices on risk of LAT and identify the optimal cut-off values by the highest Youden index. Area under the curves (AUC) were calculated and compared by DeLong test. Multiple logistic regression analyses were performed with an enter regression model in which nutritional indices and each variable with a P value < 0.05 (based on the univariable analysis) were entered. Odds ratio (OR) and 95% confidence interval (CI) were calculated to demonstrate the risk of LAT. All significance tests were two-tailed and p values < 0.05 were considered statistically significant. SPSS Statistics 26.0 (SPSS, Chicago, IL, USA) and R 4.1.2 (R Core Team, Vienna, Austria) were used to perform the statistical analysis.

Results

Patient characteristics

A total of 433 patients were enrolled in this study. The average age of included patients was 56.86 ± 9.13 years, and only 36.5% were men. 32.8% of these included patients received oral anticoagulant at admission. All anticoagulated participants received warfarin. LAT were found in 142 patients (32.79%). Patients with LAT were more likely to be male, had diabetes and heart failure, with larger LAD, lower BMI and higher level of C-reactive protein (CRP), than those without LAT (Table 1). The average PNI score and GNRI score were 49.34 ± 5.61 and 106.08 ± 9.67, respectively. Both PNI and GNRI were significantly lower in patients with LAT. The distributions of the nutritional indices were shown in Fig. 2.

Table 1 Baseline characteristics of the study population stratified by left atrial thrombus
Full size table
Fig. 2
figure 2

Distributions of nutritional indices among patients with valvular atrial fibrillation. (A) Distribution of the prognostic nutritional index (PNI). (B) Distribution of the geriatric nutritional risk index (GNRI).

Full size image

The correlation between nutritional indices and baseline variables

In correlation analysis, PNI and GNRI were positively correlated with BMI (r = 0.142, P = 0.003; r = 0.753, P < 0.001, respectively), triglyceride (r = 0.261, P < 0.001; r = 0.291, P < 0.001, respectively), low density lipoprotein cholesterol (r = 0.213, P < 0.001; r = 0.107, P = 0.040, respectively), fasting blood glucose (r = 0.129, P = 0.011; r = 0.257, P < 0.001, respectively) and negatively with CRP (r=-0.294, P < 0.001; r=-0.150, P = 0.009, respectively) (Table 2). Only PNI was positively correlated with high density lipoprotein cholesterol (r = 0.143, P = 0.005).

Table 2 Correlation analysis between prognostic nutrition index and baseline variables
Full size table

The dose-response association between nutritional indices and the risk of LAT

Dose-response curves were constructed to continuously assess the association of nutritional indices with risk of LAT. There existed a non-linear and L-shaped relationship between PNI and the risk of LAT (P for non-linearity < 0.001). With the increase of PNI, the OR decreased until it reached 49.63; thereafter, the OR tended to the horizontal line with OR = 1 (Fig. 3). GNRI had a non-linear correlation and was negative with the risk of LAT (P for non-linearity < 0.001). The OR decreased until it reached 106.78 ; thereafter, higher GNRI gradually showed a protective role (Fig. 4).

Fig. 3
figure 3

Dose-response curve of PNI and the risk of left atrial thrombus. PNI, prognostic nutritional index; OR, odds ratio; CI, confidence interval

Full size image
Fig. 4
figure 4

Dose-response curve of GNRI and the risk of left atrial thrombus. GNRI, geriatric nutritional risk index; OR, odds ratio; CI, confidence interval

Full size image

Predictive value of the Nutritional Indices for LAT

ROC analysis revealed that the optimal cutoff values of PNI and GNRI for predicting LAT were 46.4 (AUC: 0.600, 95%CI:0.541–0.658, P = 0.001; sensitivity 43.0%, specificity 76.6%) and 105.7 (AUC: 0.629, 95%CI:0.574–0.684, P < 0.001; sensitivity 61.0%, specificity 61.2%), respectively. According to pair-wise comparison of the AUC, PNI and GNRI had the similar predictive value (P = 0.286). The univariate logistic regression analysis demonstrated that male, BMI, heart failure, diabetes, larger LAD, higher serum levels of CRP, PNI < 46.4 and GNRI < 105.7 were significantly associated with higher incidence of LAT, while higher PNI and GNRI were associated with lower risk (Table 3). After adjusting gender, BMI, heart failure, diabetes, LAD, and CRP, PNI < 46.4 (OR: 2.457, 95% CI:1.333–4.526, P = 0.004) and GNRI < 105.7 (OR: 2.113, 95% CI:1.076–4.149, P = 0.030) remained independent predictors of LAT. As continuous variates, higher PNI (OR: 0.919, 95% CI:0.869–0.971, P = 0.003) and higher GNRI (OR: 0.935, 95% CI:0.891–0.980, P = 0.005) were significantly related with lower risk of LAT after adjusting for the same factors (Table 3).

Table 3 Logistics regression analysis to identify the in predictors of left atrial thrombus
Full size table

Discussion

This study is the first to explore the predictive value of nutritional indices for LAT in patients with VAF. Our principal finding was that lower nutritional indices were associated with increased risk of LAT. In addition, the two indices had different dose-response association with the occurrence of LAT. We found an L-shaped relationship between PNI and LAT. The dose-response curve flattened out near the horizontal line with OR = 1 at 49.63, indicating the risk of LAT did not decrease if PNI was greater than 49.63. GNRI was negative with the risk of LAT in a non-linear form and tended to be protective when GNRI was greater than 106.78.

To date, there existed limited information about the association between nutritional status and stroke or LAT in patients with AF. Most of these studies focused on the ‘obesity paradox’ in patients with non-valvular AF (NVAF), which referred that obesity might be associated with a lower thromboembolic risk [12,13,14]. Only one study investigated the relationship between nutritional indices and LAT in patients with AF [14]. In Wang and his colleagues’ study including 406 patients with NVAF, PNI was an independent predictor for LAT (OR: 0.89, P = 0.007), the optimal cutoff value of the PNI for predicting LAT was 48.0 (AUC: 0.68,P < 0.001) and the risk of LAT in patients with PNI ≤ 48.0 was 2.57-fold higher than that in those with PNI > 48.0 [15]. Similar to this study, our research confirmed the predictive value of PNI for LAT formation in a VAF population. Furthermore, we also found that GNRI was also an independent risk factor for LAT.

PNI and GNRI are more than nutritional indicators. Evidence showed serum albumin regulated the body’s inflammatory response and had antioxidant properties through multiple binding sites and its ability to trap free oxygen radicals [16, 17]. Previous investigations found that level of serum albumin was negatively correlated with serum inflammatory biomarkers [18]. Hypoalbuminemia was also found to increase susceptibility to thrombotic events in patients with cardiovascular disorders [19]. Low lymphocyte count is common in cardiovascular diseases as a chronic inflammatory response. Several mechanisms for this phenomenon have been postulated, the most important being: (1) redistribution of lymphocytes from peripheral blood to other sites (infiltration of activated T-cells in heart tissues) and (2) accelerating cell death due to apoptosis [20]. Low lymphocyte count is also associated with poor prognosis in patients with a wide variety of diseases [20]. Our study and previous researches found that PNI and GNRI correlated with inflammatory markers such as CRP or neutrophil-to-lymphocyte ratio [15, 21]. The above evidence suggested that PNI and GNRI could not only evaluate the nutritional status but also effectively reflect the immune and inflammation status of the body. The presence of systemic inflammation in VAF patients was found by measuring serum inflammatory biomarkers or histopathological examination of the left atrium [22, 23]. Inflammation also caused and exaggerated the structural and electrical remodeling of the atria, leading to ineffective irregular contraction and blood stasis [22, 23]. Blood stasis in the left atrium resulted in thrombogenic tendency in patients with VAF. A recent study found higher level of serum inflammatory biomarkers to be statistically significant predictors of LAT in patients with VAF [24]. Therefore, in view of our study and findings from previous investigations, systemic inflammation might also contribute to the association between the indices examined in this study and LAT in VAF patients. However, the major difference between the two indices is that GNRI includes anthropometric factors (the ratio of body weight to ideal body weight). GNRI is a multidimensional indicator. Besides systemic inflammation, metabolic factors also have large impact on this score. PNI only consists of serum markers, so it is more susceptible to systemic inflammation. We postulated that lower level of systemic inflammation reduced the risk of LAT, but it could not be protective. This might contribute to the L-shaped dose-response curve between PNI and LAT. The different dose-response curves of the two indices indicated that, in patients with over-nutrition status such as overweight, PNI might not discriminate those with high risk of LAT while GNRI could. Therefore, this might be an advantage of GNRI over PNI.

Evaluation for nutrition status in patients with VAF and performing early interventions for malnutrition might be of high importance for their prognosis. Malnutrition is not only a marker of disease severity but also a contributor of disease progression. Long-term chronic disease, such as VAF, leads to malnutrition, which expedites the progression of the disease [7]. Sunaga et al. found improvement in nutritional status during hospitalization were associated with better prognosis in patients with malnutrition and heart failure [25]. Felipe et al. showed polyunsaturated fatty acids and antioxidant vitamins could reduce oxidative and nitrosative stress and prevent Cx40/Cx43 lateralization in atrial tissue to avoid AF occurrence [26]. Clinical trial had also demonstrated that micronutrient supplementation might prevent ischaemic events in patients with high risk of stroke [27]. Similar effects may be achieved to reduce thromboembolic risk when nutritional treatment is administered to patients with VAF. Further studies are needed to determine whether nutrition interventions can reduce thromboembolic risk in patients with VAF.

The prevalence of LAT varied in prior reports due to the proportion of receiving anticoagulants. Left atrial thrombus were found in approximately 5–27% of AF patients without anticoagulation therapy [28]. In our study, the occurrence of LAT was 32.79% with a relative low rate of oral anticoagulation therapy(32.8%). 60.3% patients in the present study were diagnosed AF for the first time. This partly contribute to the low prevalence of anticoagulation. Underuse of oral anticoagulation in VAF was also observed in other researches [28, 29]. In nationwide Danish registries from 2000 to 2018, only 54% VAF patients received oral anticoagulant therapy [29]. VAF patients had more commodities, such as heart failure and malnutrion, increasing the bleeding risk. It might cause the hesitation to anticoagulant therapy.

All VAF patients are indicated for anticoagulation therapy. Warfarin have been proven to be effective in the prevention of LAT [1]. However, in patients with nutritional problems, drug metabolism and food interaction may influence the efficacy of warfarin for thromboembolic prevention. In our study, participants with lower nutritional indices had higher risk of LAT, but those patients were also considered with higher risk of bleeding in previous research [30]. Therefore, patients with lower PNI or GNRI required more frequent follow-up and close monitoring of time in therapeutic range. Measuring those nutritional indices may help anticoagulant strategy in clinical practice.

Despite the crucial findings being mentioned, our study had some limitations. First, it was a retrospective observational study including a small number of hospitalized patients. The enrollment of patients was not randomized, there might exist selection bias. The malnutrition status of hospitalized patients with VAF did not precisely reflect the malnutrition status in the overall population with VAF. More prospective studies with larger samples are needed to further validate our findings. Secondly, besides LAD, other echocardiographic paramters for thromboembolic risk in AF patients, such as left atrial volume index, left atrial appendage area and left atrial appendage wall motion velocity, were not routinely measured in our center [31]. In addition, in the anticoagulated patients enrolled in our study, we did not have information about the quality of anticoagulant control (e.g.time in therapeutic range for patients receiving warfarin and actual intake of oral anticoagulants), which impact the risk of LAT. Furthermore, we only used two simple indices to evaluate the nutritional status but did not compare the predictive value of more comprehensive and complex nutritional screening tools [32]. Finally, the nutritional indices were assessed only at admission; subsequent temporal changes and their relationship with endpoints could not be assessed. Dynamic monitoring of these indices could provide more information.

Conclusions

In summary, we reported that lower nutritional indices (GNRI and PNI) were associated with higher risk for LAT in a VAF population. These two indices could be used as cost-effective predictors for thromboembolic risk in patients with VAF due to their low cost and easy accessibility, especially in low- and middle- income countries.

Data availability

The datasets generated and analysed during the current study are not publicly available due to the Henan Provincial People’s Hospital regulations, but are available from the corresponding author on reasonable request.

Abbreviations

AF:

Atrial fibrillation

NVAF:

Non-valvular atrial fibrillation

VAF:

Valvular atrial fibrillation

LAT:

Left atrial thrombus

CRP:

C-reactive protein

BMI:

Body mass index

PNI:

Prognostic nutritional index

GNRI:

Geriatric nutritional risk index

TEE:

Transesophageal echocardiography

LAD:

Left atrium diameter

LVEF:

Left ventricular ejection fraction

ROC:

Receiver operating characteristic curve

AUC:

Area under the curve

OR:

Odds ratio

CI:

Confidence Interval

References

  1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498. https://0-doi-org.brum.beds.ac.uk/10.1093/eurheartj/ehaa612.

    Article  PubMed  Google Scholar 

  2. Lip GYH, Collet JP, Caterina R, Fauchier L, Lane DA, Larsen TB, et al. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and european Society of Cardiology Working Group on thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), south african heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace. 2017;19:1757–8. https://0-doi-org.brum.beds.ac.uk/10.1093/europace/eux240.

    Article  PubMed  Google Scholar 

  3. De Caterina R, Camm AJ. What is ‘valvular’ atrial fibrillation? A reappraisal. Eur Heart J. 2014;35:3328–35. https://0-doi-org.brum.beds.ac.uk/10.1093/eurheartj/ehu352.

    Article  CAS  PubMed  Google Scholar 

  4. Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, et al. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry. Circulation. 2014;129:1568–76. https://0-doi-org.brum.beds.ac.uk/10.1161/CIRCULATIONAHA.113.005451.

    Article  PubMed  Google Scholar 

  5. Menke J, Lüthje L, Kastrup A, Larsen J. Thromboembolism in atrial fibrillation. Am J Cardiol. 2010;105:502–10. https://0-doi-org.brum.beds.ac.uk/10.1016/j.amjcard.2009.10.018.

    Article  PubMed  Google Scholar 

  6. Arenas Miquélez A, Requena Calleja MA, Gullón A, Pose Reino A, Formiga F, Camafort M, et al. Nutritional risk and mortality at one year for Elderly Patients hospitalized with Nonvalvular Atrial Fibrillation. Nonavasc Registry. J Nutr Health Aging. 2020;24:981–6. https://0-doi-org.brum.beds.ac.uk/10.1007/s12603-020-1418-0.

    Article  PubMed  Google Scholar 

  7. Kalantar-Zadeh K, Anker SD, Horwich TB, Fonarow GC. Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol. 2008;101:89e–103e. https://0-doi-org.brum.beds.ac.uk/10.1016/j.amjcard.2008.03.007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Cheng N, Dang A, Lv N, He Y, Wang X. Malnutrition status in patients of very advanced age with nonvalvular atrial fibrillation and its impact on clinical outcomes. Nutr Metab Cardiovasc Dis. 2019;29:1101–9. https://0-doi-org.brum.beds.ac.uk/10.1016/j.numecd.2019.06.021.

    Article  PubMed  Google Scholar 

  9. Bouillanne O, Morineau G, Dupont C, Coulombel I, Vincent JP, Nicolis I, et al. Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005;82:777–83. https://0-doi-org.brum.beds.ac.uk/10.1093/ajcn/82.4.777.

    Article  CAS  PubMed  Google Scholar 

  10. Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF. Prognostic nutritional index in gastrointestinal surgery. Am J Surg 1980;139:160-7. Am J Surg.1980;139:160–167. https://0-doi-org.brum.beds.ac.uk/10.1016/0002-9610(80)90246-9.

  11. Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, et al. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr. 2013;26:921–64. https://0-doi-org.brum.beds.ac.uk/10.1016/j.echo.2013.07.009.

    Article  PubMed  Google Scholar 

  12. Sandhu RK, Ezekowitz J, Andersson U, Alexander JH, Granger CB, Halvorsen S, et al. The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for reduction in stroke and other thromboembolic events in Atrial Fibrillation) trial. Eur Heart J. 2016;37:2869–78. https://0-doi-org.brum.beds.ac.uk/10.1093/eurheartj/ehw124.

    Article  PubMed  Google Scholar 

  13. Boriani G, Ruff CT, Kuder JF, Shi M, Lanz HJ, Rutman H, et al. Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial. Eur Heart J. 2019;40:1541–50. https://0-doi-org.brum.beds.ac.uk/10.1093/eurheartj/ehw124.

    Article  CAS  PubMed  Google Scholar 

  14. Li YG, Xie PX, Alsheikh-Ali AA, AlMahmeed W, Sulaiman K, Asaad N, et al. The obesity paradox in patients with atrial fibrillation: insights from the Gulf SAFE registry. Front Cardiovasc Med. 2022;9:1032633. https://0-doi-org.brum.beds.ac.uk/10.3389/fcvm.2022.1032633.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Wang Z, Wang B, Fu G, He B, Chu H, Zhang S. The Prognostic Nutritional Index May Predict Left Atrial appendage Thrombus or dense spontaneous Echo contrast in patients with Atrial Fibrillation. Front Cardiovasc Med. 2022;9:860624. https://0-doi-org.brum.beds.ac.uk/10.3389/fcvm.2022.860624.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: Pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr. 2019;43(2):181–93. https://0-doi-org.brum.beds.ac.uk/10.1002/jpen.1451.

    Article  CAS  PubMed  Google Scholar 

  17. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582:1783–7. https://0-doi-org.brum.beds.ac.uk/10.1016/j.febslet.2008.04.057.

    Article  CAS  PubMed  Google Scholar 

  18. Sheinenzon A, Shehadeh M, Michelis R, Shaoul E, Ronen O. Serum albumin levels and inflammation. Int J Biol Macromol. 2021;184:857–62. https://0-doi-org.brum.beds.ac.uk/10.1016/j.ijbiomac.2021.06.140.

    Article  CAS  PubMed  Google Scholar 

  19. Ronit A, Kirkegaard-Klitbo DM, Dohlmann TL, Lundgren J, Sabin CA, Phillips AN, et al. Plasma albumin and Incident Cardiovascular Disease: results from the CGPS and an updated Meta-analysis. Arterioscler Thromb Vasc Biol. 2020;40:473–82. https://0-doi-org.brum.beds.ac.uk/10.1161/ATVBAHA.119.313681.

    Article  CAS  PubMed  Google Scholar 

  20. Núñez J, Miñana G, Bodí V, Núñez E, Sanchis J, Husser O, et al. Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18:3226–33. https://0-doi-org.brum.beds.ac.uk/10.2174/092986711796391633.

    Article  PubMed  Google Scholar 

  21. Gärtner S, Kraft M, Krüger J, Vogt LJ, Fiene M, Mayerle J, et al. Geriatric nutritional risk index correlates with length of hospital stay and inflammatory markers in older inpatients. Clin Nutr. 2017;36:1048–53. https://0-doi-org.brum.beds.ac.uk/10.1016/j.clnu.2016.06.019.

    Article  PubMed  Google Scholar 

  22. Sharma S, Sharma G, Hote M, Devagourou V, Kesari V, Arava S, et al. Light and electron microscopic features of surgically excised left atrial appendage in rheumatic heart disease patients with atrial fibrillation and sinus rhythm. Cardiovasc Pathol. 2014;23:319–26. https://0-doi-org.brum.beds.ac.uk/10.1016/j.carpath.2014.07.008.

    Article  PubMed  Google Scholar 

  23. Yongjun Q, Huanzhang S, Wenxia Z, Hong T, Xijun X. Histopathological characteristics and oxidative injury secondary to atrial fibrillation in the left atrial appendages of patients with different forms of mitral valve disease. Cardiovasc Pathol. 2013;22:211–8. https://0-doi-org.brum.beds.ac.uk/10.1016/j.carpath.2012.10.002.

    Article  CAS  PubMed  Google Scholar 

  24. Zhou Y, Song X, Ma J, Wang X, Fu H. Association of inflammation indices with left atrial thrombus in patients with valvular atrial fibrillation. BMC Cardiovasc Disord. 2023;23:9. https://0-doi-org.brum.beds.ac.uk/10.1186/s12872-023-03036-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Sunaga A, Hikoso S, Yamada T, Yasumura Y, Tamaki S, Yano M, et al. Change in Nutritional Status during hospitalization and prognosis in patients with heart failure with preserved ejection fraction. Nutrients. 2022;14:4345. https://0-doi-org.brum.beds.ac.uk/10.3390/nu14204345.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Petersen F, Rodrigo R, Richter M, Kostin S. The effects of polyunsaturated fatty acids and antioxidant vitamins on atrial oxidative stress, nitrotyrosine residues, and connexins following extracorporeal circulation in patients undergoing cardiac surgery. Mol Cell Biochem. 2017;433:27–40. https://0-doi-org.brum.beds.ac.uk/10.1007/s11010-017-3013-1.

    Article  CAS  PubMed  Google Scholar 

  27. Hankey GJ, Eikelboom JW, Yi Q, Lees KR, Chen C, Xavier D, et al. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial. Lancet Neurol. 2012;11:512–20. https://0-doi-org.brum.beds.ac.uk/10.1016/S1474-4422(12)70091-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Shi S, Zhao Q, Liu T, Zhang S, Liang J, Tang Y, et al. Left atrial Thrombus in patients with non-valvular atrial fibrillation: a cross-sectional study in China. Front Cardiovasc Med. 2022;9:827101DOI. https://0-doi-org.brum.beds.ac.uk/10.3389/fcvm.2022.827101.

    Article  CAS  Google Scholar 

  29. Melgaard L, Jensen M, Overvad TF, Larsen TB, Lip GYH, Nielsen PB. Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: a descriptive nationwide cohort study. Int J Clin Pract. 2020;74(10):e13589. https://0-doi-org.brum.beds.ac.uk/10.1111/ijcp.13589.

    Article  PubMed  Google Scholar 

  30. Raposeiras-Roubín S, Abu-Assi E, Paz RC, Rosselló X, Barreiro Pardal C, Piñón Esteban M, et al. Impact of malnutrition in the embolic-haemorrhagic trade-off of elderly patients with atrial fibrillation. Europace. 2020;22(6):878–87. https://0-doi-org.brum.beds.ac.uk/10.1093/europace/euaa017.

    Article  PubMed  Google Scholar 

  31. Fukuda Y, Okamoto M, Tomomori S, Matsumura H, Tokuyama T, Nakano Y, et al. In paroxysmal atrial fibrillation patients, the Neutrophil-to-lymphocyte ratio is related to Thrombogenesis and more closely Associated with Left Atrial Appendage Contraction than with the left atrial body function. Intern Med. 2018;57:633–40. https://0-doi-org.brum.beds.ac.uk/10.2169/internalmedicine.9243-17.

    Article  CAS  PubMed  Google Scholar 

  32. Dent E, Hoogendijk EO, Visvanathan R, Wright ORL. Malnutrition Screening and Assessment in Hospitalised Older People: a review. J Nutr Health Aging. 2019;23:431–41. https://0-doi-org.brum.beds.ac.uk/10.1007/s12603-019-1176-z.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

This study was supported by Joint Construction Project of Henan Medical Science and Technology Research Plan (No. LHGJ20210093 ).

Author information

Author notes

  1. These authors have contributed equally to this work and share first authorship.

Authors and Affiliations

  1. Heart center of Henan Provincial People’s Hospital, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, NO.1 Fuwai Avenue, Zhengdong New District, Zhengzhou, 450003, Henan, China

    You Zhou, Erpeng Liang, Jifang Ma, Xianqing Wang & Haixia Fu

Authors
  1. You Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erpeng Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jifang Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xianqing Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Haixia Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YZ and HXF contributed to the conception or design of the work. YZ, EL, JFM and XQW contributed to the acquisition, analysis, or interpretation of data for the work. YZ and EL drafted the manuscript. HXF critically revised the manuscript. All gave final approval and agree to be accountable for all aspects of work ensuring integrity and accuracy.

Corresponding author

Correspondence to Haixia Fu.

Ethics declarations

Ethics approval and consent to participate

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of the Henan Provincial People’s Hospital. The need for informed consent was waived by the Ethics Committee of the Henan Provincial People’s Hospital, because of the retrospective nature of the study.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, Y., Liang, E., Ma, J. et al. Predictive value of nutritional indices for left atrial thrombus in patients with valvular atrial fibrillation. BMC Cardiovasc Disord 23, 526 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s12872-023-03493-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12872-023-03493-4

Keywords

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us